CLINICAL_TRIALS
trial_result
· 2014-11-07
Clinical Trial Update: IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia [Phase 2]
Summary
Phase 2 trial update on IL-11 for women with von Willebrand disease and refractory menorrhagia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Margaret Ragni | Conditions: Von Willebrand Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-11-07